Granting Stock Acquisition Rights to Directors, Audit & Supervisory Board Members, and Executive Officers with Titles
First written in FY2018-Q2. 2 of 5 entries say "Advanced", first in FY2018. Latest entry: FY2020.
The whole theme swung hardest in 2021: 4 of 33 companies on the "Worse" side.
9 other companies' latest entry also says "Dropped".
- FY2020DroppedAnnual report
「At the general meeting of shareholders held on 24 June 2020, the company introduced a restricted stock compensation plan as share-price-linked compensation. At the same time, it abolished the stock option plan in the form of share-based compensation, approved at the general meeting of shareholders held on 27 June 2012, except for rights already granted, and decided not to make any further grants of stock acquisition rights as stock-based compensation stock options for directors.」
Except for rights already granted, the company has discontinued new issuances of stock-based compensation stock options for directors and transitioned to a restricted stock compensation plan. - FY2020-Q2RestatedAnnual report
「Date of resolution 25 June 2019 Categories and number of grantees (people) 9 of the company’s directors (excluding outside directors) 2 of the company’s executive officers with titles (excluding those who also serve as directors) Number of stock acquisition rights (units) ※ 283 Class, description and number of shares underlying the stock acquisition rights (shares) ※ Common shares 28,300」
For the 8th Series of Stock Acquisition Rights resolved on 25 June 2019, the company continues to disclose the issuance of 283 units covering 28,300 shares for 9 directors and 2 executive officers with titles. - FY2019AdvancedAnnual report
「8th Series of Stock Acquisition Rights Date of resolution 25 June 2019 Categories and number of grantees 9 of the company’s directors (excluding outside directors) 2 of the company’s executive officers with titles (excluding those who also serve as directors) Class and number of shares granted (shares) (Note) 1 Common shares 28,300」
The company has disclosed the grant of 28,300 shares under the 8th Series of Stock Acquisition Rights to 9 directors and 2 executive officers with titles, as resolved on 25 June 2019 after the filing date. - FY2018AdvancedAnnual report
「7th Series of Stock Acquisition Rights Date of resolution 26 June 2018 Categories and number of grantees 9 of the company’s directors (excluding outside directors) 2 of the company’s executive officers with titles (excluding those who also serve as directors) Class and number of shares granted (shares) (Note) 1 Common shares 21,100」
The company has disclosed the grant of 21,100 shares under the 7th Series of Stock Acquisition Rights to directors and executive officers with titles. - FY2018-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Number of stock acquisition rights 189 Number of shares underlying the stock acquisition rights (shares) 18,900 Exercise period for the stock acquisition rights From 2 August 2017 To 1 August 2047 Payment amount upon exercise of the stock acquisition rights ¥1」
During the second quarter accounting period, the company issued 189 stock acquisition rights covering 18,900 underlying shares. The exercise period runs from 2 August 2017 to 1 August 2047, and the exercise terms provide for exercise after the holders cease to be directors, audit & supervisory board members or executive officers with titles.